Literature DB >> 2893412

Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.

F Gilbert1, C T Dourish.   

Abstract

The effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), were examined. Gepirone dose-dependently increased feeding 2 and 4 h after injection, the magnitude of the response being larger than previously observed with any other 5-HT1A receptor ligand. Previous studies have suggested that buspirone and ipsapirone can block some of the behavioural effects of 8-OH-DPAT. However, gepirone, buspirone and ipsapirone did not inhibit feeding induced by 8-OH-DPAT. These results indicate that gepirone is a very efficacious appetite stimulant in rats and suggest that gepirone, buspirone and ipsapirone act as 5-HT autoreceptor agonists in the feeding model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893412     DOI: 10.1007/bf00187255

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.

Authors:  C T Dourish; P H Hutson; G A Kennett; G Curzon
Journal:  Appetite       Date:  1986       Impact factor: 3.868

2.  Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

Authors:  A S Eison; M S Eison; M Stanley; L A Riblet
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

3.  Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.

Authors:  B A McMillen; L A Mattiace
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

4.  Effects of 5-HT1A selective anxiolytics on lordosis behavior: interactions with progesterone.

Authors:  S D Mendelson; B B Gorzalka
Journal:  Eur J Pharmacol       Date:  1986-12-16       Impact factor: 4.432

5.  Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

Authors:  J Traber; M A Davies; W U Dompert; T Glaser; T Schuurman; P R Seidel
Journal:  Brain Res Bull       Date:  1984-06       Impact factor: 4.077

6.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

7.  8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.

Authors:  C Bendotti; R Samanin
Journal:  Eur J Pharmacol       Date:  1986-02-11       Impact factor: 4.432

8.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

9.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

Authors:  C P VanderMaelen; G K Matheson; R C Wilderman; L A Patterson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

10.  Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.

Authors:  P H Hutson; C T Dourish; G Curzon
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

View more
  14 in total

1.  8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.

Authors:  J K Shepherd; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Influence of taste and food texture on the feeding responses induced by 8-OH-DPAT and gepirone.

Authors:  P J Fletcher; M H Zack; D V Coscina
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Behavioural evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype.

Authors:  S P Vickers; P G Clifton; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

6.  The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.

Authors:  P J Fletcher; M Davies
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

7.  Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.

Authors:  G P Luscombe; K F Martin; L J Hutchins; J Gosden; D J Heal
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

8.  Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery.

Authors:  D C Blanchard; J K Shepherd; R J Rodgers; R J Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Investigating the motivational mechanism of altered saline consumption following 5-HT(1A) manipulation.

Authors:  Melissa L Caras; Kimberly MacKenzie; Benjamin Rodwin; Donald B Katz
Journal:  Behav Neurosci       Date:  2008-04       Impact factor: 1.912

Review 10.  Molecular signaling involved in regulating feeding and other motivated behaviors.

Authors:  Todd R Gruninger; Brigitte LeBoeuf; Yishi Liu; L Rene Garcia
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.